Merck Strikes $1.35 Billion Deal for Bone-Marrow Disease Drug Developer

Health Merck agrees to pay $36 a share cash for Imago BioSciences

Opinion | The FDA and an ALS Treatment

Few diseases are as cruelly debilitating as amyotrophic lateral sclerosis (ALS). But a Food and Drug…

TMC Gets Approval for Pilot Deep-Sea Mining Project

Deep-sea mining for battery metals is moving a step closer to reality after one of the…

FDA Approves New Botox Rival

The U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most…

Opinion | Look Who’s Rushing Covid Vaccines Now

Democrats and the public-health clerisy denounced President Trump for rushing Covid vaccines. They’ve been curiously quiet…

Covid-19 Booster Shots Targeting Omicron Authorized, Likely to Be Offered Soon

U.S. health regulators cleared use of retooled Covid-19 vaccines that target the latest versions of Omicron,…

Pfizer, BioNTech Ask FDA to Green Light Tweaked Covid-19 Vaccine

This copy is for your personal, non-commercial use only. Distribution and use of this material are…

How Occidental Petroleum Captured Warren Buffett’s Eye

As the pandemic set in, investors including Warren Buffett ditched shares of Occidental Petroleum Now, the…

FDA Approves Bluebird’s $2.8 Million Gene Therapy for Rare Blood Disease

The Food and Drug Administration approved a gene therapy from Bluebird Bio Inc. that represents a…

Pfizer Agrees to $5.4 Billion Deal for Global Blood Therapeutics

Updated Aug. 8, 2022 7:11 am ET Pfizer Inc. has agreed to buy Global Blood Therapeutics…